Stelara and Valacyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Stelara (ustekinumab) and Valacyclovir (valacyclovir hydrochloride). Common drug interactions include superinfection bacterial among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Stelara and Valacyclovir. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Stelara?

Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,108 Valacyclovir users. Check the latest studies of Valacyclovir.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Jul, 04, 2026

59 people who take Stelara and Valacyclovir together, and have interactions are studied.

Stelara and Valacyclovir drug interactions.

What are the common drug interactions of Stelara and Valacyclovir, by gender? *:

female:

  1. Superinfection bacterial
  2. Superinfection fungal
  3. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  4. Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  5. Premature baby
  6. Intussusception
  7. Respiratory syncytial virus infection (viral disease of respiratory system)
  8. Sinusitis (inflammation of sinus)
  9. Urinary tract infection
  10. Gestational hypertension (elevated blood pressure during pregnancy)

male:

  1. Abdominal pain
  2. Intestinal haematoma (collection of blood, usually clotted, in intestine)
  3. Intestinal resection
  4. Jugular vein thrombosis (clot in jugular vein)
  5. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  6. Nausea (feeling of having an urge to vomit)
  7. Red blood cell macrocytes present
  8. Subclavian vein thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein)
  9. Wound infection
  10. Abdominal pain lower

What are the common drug interactions of Stelara and Valacyclovir, by age (0-1 to 60+)? *:

0-1:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  3. Premature baby
  4. Intussusception
  5. Respiratory syncytial virus infection (viral disease of respiratory system)

2-9:

n/a

10-19:

  1. Intestinal haematoma (collection of blood, usually clotted, in intestine)
  2. Abdominal pain
  3. Pyrexia (fever)

20-29:

  1. Gestational hypertension (elevated blood pressure during pregnancy)
  2. Premature labour
  3. Sinusitis (inflammation of sinus)
  4. Urinary tract infection
  5. Anal abscess
  6. Postoperative wound infection

30-39:

  1. Decreased interest
  2. Depressed mood
  3. Depression
  4. Gestational hypertension (elevated blood pressure during pregnancy)
  5. Premature labour
  6. Sinusitis (inflammation of sinus)
  7. Urinary tract infection
  8. Abdominal pain
  9. Abdominal symptom
  10. Gastrointestinal disorder (functional problems of gastrointestinal tract)

40-49:

  1. Injection site erythema (redness at injection site)
  2. Injection site swelling
  3. Injection site urticaria (rash of round, red welts on the skin at injection site)
  4. Injection site vesicles (fluid- or air-filled cavity or sac at injection site)
  5. Injection site warmth
  6. Neuralgia (pain in one or more nerves)
  7. Precancerous skin lesion
  8. Proctitis ulcerative (inflammation of the rectum and anus ulcerative)
  9. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  10. Tongue discolouration (colour change of tongue)

50-59:

  1. Optic nerve injury
  2. Abdominal hernia
  3. Abdominal pain upper
  4. Dehydration (dryness resulting from the removal of water)
  5. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  6. Hospitalisation

60+:

  1. Abdominal pain
  2. Neoplasm malignant (cancer tumour)
  3. Lung neoplasm malignant (cancer tumour of lung)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Urinary tract infection
  6. Colitis (inflammation of colon)
  7. Drug ineffective
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Groin pain
  10. Hepatic enzyme increased

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 19 people, 32.20%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 10 people, 16.95%
  3. Herpes Virus Infection: 8 people, 13.56%
  4. Sleep Disorder: 8 people, 13.56%
  5. Spondyloarthropathy (any joint disease of the vertebral column): 6 people, 10.17%
  6. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 6 people, 10.17%
  7. Urinary Tract Infection: 5 people, 8.47%
  8. Sinusitis (inflammation of sinus): 5 people, 8.47%
  9. Multiple Allergies (allergy to multiple agents): 5 people, 8.47%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Stelara and Valacyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Stelara and Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Stelara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Stelara and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ustekinumab and valacyclovir hydrochloride (the active ingredients of Stelara and Valacyclovir, respectively), and Stelara and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: